GRST (Ethema Health) EBITDA Margin %: 18.72% (As of Sep. 2025) — 28% Above Median


What is Ethema Health EBITDA Margin %?

Ethema Health GRST EBITDA Margin % is 18.72% as of Sep. 2025, which is 28% above its 10-year median of 14.65. The stock has 3 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Ethema Health ranks better than 54.49% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Ethema Health's EBITDA for the three months ended in Sep. 2025 was $1.04 Mil. Ethema Health's Revenue for the three months ended in Sep. 2025 was $5.53 Mil. Therefore, Ethema Health's EBITDA margin for the quarter that ended in Sep. 2025 was 18.72%.


Ethema Health  (OTCPK:GRST) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Ethema Health EBITDA Margin % Related Terms


Ethema Health EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Ethema Health's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ethema Health EBITDA Margin % Chart

Ethema Health Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,399.71 71.28 50.22 38.77 -9.47

Ethema Health Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -28.75 13.50 -2.08 12.74 18.72

GRST vs PAIYY, NIVF, BACK: EBITDA Margin % Comparison

For the Medical Care Facilities subindustry, Ethema Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ethema Health EBITDA Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ethema Health's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Ethema Health's EBITDA Margin % falls into.



Ethema Health EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Ethema Health's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-0.57/6.017
=-9.47 %

Ethema Health's EBITDA Margin % for the quarter that ended in Sep. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=1.035/5.529
=18.72 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 18.72% mean?
Ethema Health (GRST) has a EBITDA Margin % of 18.72% as of Sep. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ethema Health and its competitors. This is 28% above median its historical median of 14.65. According to the industry distribution chart, Ethema Health ranks #304 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 45.5%.
Is Ethema Health's EBITDA Margin % too high?
Ethema Health's current EBITDA Margin % of 18.72% is 28% above median its 10-year median of 14.65. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Ethema Health's value of 18.72% is 83.3% above this industry median. Based on the distribution chart, Ethema Health ranks #304 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint.
How does Ethema Health's EBITDA Margin % compare to PAIYY and NIVF?
According to the Healthcare Providers & Services industry distribution chart, Ethema Health ranks #304 out of 668 companies for EBITDA Margin %. This puts Ethema Health in the upper half of its industry. The industry median EBITDA Margin % is 10.21. Ethema Health's value of 18.72% is 83.3% above this benchmark. While the company's 10-year median is 14.65 vs. the industry median of 10.21, Ethema Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ethema Health's current EBITDA Margin % of 18.72% is 83.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ethema Health and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ethema Health's current EBITDA Margin % is 18.72%, which is 28% above median its own 10-year median of 14.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ethema Health stock overvalued right now?
Ethema Health (GRST) has a current EBITDA Margin % of 18.72%. The current EBITDA Margin % is 18.72%, which is 28% above median its 10-year median of 14.65 and 83.3% above the Healthcare Providers & Services industry median of 10.21. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Ethema Health (GRST), the current EBITDA Margin % is 18.72% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ethema Health Business Description

Address 950 Evernia Street, West Palm Beach, FL, USA, 33401
Ethema Health Corp is engaged in developing and operating medical clinics in Delray Beach Florida. It provides addiction and mental health treatment facilities. The company's operating segment includes Rehabilitation Services provided to customers. It generates maximum revenue from the In-Patient services segment.